Stock Events

Stock Events

Achieve Life Sciences 

€3.68
74
+€0.1+2.85% Monday 06:03

Statistics

Day High
3.68
Day Low
3.68
52W High
4.97
52W Low
1.79
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Next
-0.25
0.08
0.41
0.75
Expected EPS
-0.25479750569
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SP4P.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap149.77B
Pfizer is involved in developing treatments in various therapeutic areas, including smoking cessation aids which compete with Achieve Life Sciences' cytisinicline product.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline produces Nicorette, a nicotine replacement therapy, directly competing with Achieve's smoking cessation products.
Altria Group
MO
Mkt Cap124.64B
Altria Group, through its investments in nicotine replacement and cessation products, competes in the same market as Achieve Life Sciences.
British American Tobacco
BTI
Mkt Cap127.04B
British American Tobacco, with its investments in smoking cessation tools and nicotine replacement therapies, competes with Achieve Life Sciences.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its subsidiary producing Nicorette, competes in the nicotine replacement therapy market.
Novartis
NVS
Mkt Cap279.67B
Novartis offers smoking cessation products, which places it in direct competition with Achieve Life Sciences.
Merck
MRK
Mkt Cap277.02B
Merck & Co., Inc. competes through its research and development in therapies that could potentially include smoking cessation aids.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie, with its broad interest in healthcare solutions, could potentially compete in the smoking cessation aid market.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.7B
Teva Pharmaceutical Industries competes in the generic drug market, including potential production of smoking cessation aids.
22nd Century Group
XXII
Mkt Cap1.52M
22nd Century Group, Inc. specializes in tobacco products with reduced nicotine levels, indirectly competing with smoking cessation aids.

About

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
Show more...
CEO
ISIN
US0044685008

Listings

XNAS
US
ACHV
STU
DE
SP4P.STU
F
DE
SP4P.F
MU
DE
SP4P.MU

0 Comments

Share your thoughts

FAQ

What is Achieve Life Sciences stock price today?▼
The current price of SP4P.MU is €3.68 EUR — it has increased by +2.85% in the past 24 hours. Watch Achieve Life Sciences stock price performance more closely on the chart.
What is Achieve Life Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Achieve Life Sciences stocks are traded under the ticker SP4P.MU.
Is Achieve Life Sciences stock price growing?▼
SP4P.MU stock has risen by +8.24% compared to the previous week, the month change is a +37.24% rise, over the last year Achieve Life Sciences has showed a +61.67% increase.
When is the next Achieve Life Sciences earnings date?▼
Achieve Life Sciences is going to release the next earnings report on May 07, 2026.
In which sector is Achieve Life Sciences located?▼
Achieve Life Sciences operates in the Other sector.
When did Achieve Life Sciences complete a stock split?▼
Achieve Life Sciences has not had any recent stock splits.